Peer-influenced content. Sources you trust. No registration required. This is HCN.

Clinical Infectious Diseases (CID)National Trends in Congenital Syphilis Among US Newborns, 2012–2022

ℹ️ Observational Association Only Evidence

Researchers analyzed the 2012, 2016, 2019, and 2022 Kids’ Inpatient Database to examine congenital syphilis trends among US live birth hospitalizations. The sample included 5.2 million unweighted records, representing 14.6 million birth hospitalizations and 6,560 neonates with congenital syphilis. Rates increased from 16.0 to 94.7 per 100,000 birth hospitalizations. Cases were identified through diagnosis codes; the analysis excluded out-of-hospital births, transferred infants, and fetal losses.


Clinical Considerations

  • Overall increase: The rate rose 5.9-fold (95% CI, 4.9–7.2), an absolute increase of 78.7 per 100,000 birth hospitalizations (95% CI, 69.4–88.1).
  • Racial and ethnic differences: American Indian/Alaska Native neonates had the largest fold increase: 21.5 (95% CI, 8.8–52.1), reaching 486.0 per 100,000 in 2022.
  • Socioeconomic patterns: In 2022, rates were highest in the lowest-income ZIP code quartile and among publicly insured newborns: 186.8 and 177.4 per 100,000, respectively.
  • Regional distribution: The West had the highest 2022 rate, at 126.0 per 100,000; the South accounted for more than half of cases.
  • Potential underestimation: Asymptomatic infections and excluded births or fetal losses may reduce case capture. Federal facilities, including Indian Health Service hospitals, were excluded.
  • Data limitations: Maternal antibiotic treatment was unavailable. Changing state participation may affect comparisons, and the database does not support state-level analyses.

Practice Applications

  • Prenatal prevention: The authors call for improved prenatal screening, timely maternal diagnosis and treatment, and reductions in syphilis among women of reproductive age.
  • Medication availability: The article identifies reliable benzathine penicillin G supply as a prevention priority; the study did not measure shortage-related effects.
  • Evidence boundaries: Prenatal-care barriers, substance use, and service disruptions are discussed as possible contributors, not causes established by this analysis.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form